Back to Authors

Rajkumar, S. Vincent

https://orcid.org/0000-0002-5862-1833

A5066940168 | I1330342723

Mayo Clinic

Citations 920

Monoclonal Gammopathy of Undetermined Significance

Annals of Internal Medicine | December 12, 2022 | Volume: 175 | Issue: 12 | Pages: ITC177-ITC192

10.7326/aitc202212200 | PMID 36508741

AI-Enabled Screening for Drug Repurposing in Monoclonal Gammopathy of Undetermined Significance

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7842-7843

10.1182/blood-2022-169376

Single-Cell Dissection of Primary Quadruplet- and Triplet-Resistant Multiple Myeloma

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9978-9979

10.1182/blood-2022-162679

Persistance or Reappearance of Serum Monoclonal Protein Detected By Mass Spectrometry Is a Major Prognostic Factor in Patients with Newly Diagnosed Multiple Myeloma

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2347-2348

10.1182/blood-2022-167430

Fixed Duration Daratumumab, Ixazomib, Lenalidomide, and Dexamethasone Quadruplet for Newly Diagnosed Multiple Myeloma - MRD Negativity and Survival Outcomes

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10142-10143

10.1182/blood-2022-169046

Outcomes of Multiple Myeloma Patients Refractory to Standard Dose Vs Low Dose Lenalidomide

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9998-9999

10.1182/blood-2022-160368

Muscle and Fat Composition in Patients with Newly Diagnosed Multiple Myeloma

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7141-7143

10.1182/blood-2022-163746

Immunoglobulin Heavy Chain Amyloidosis: Patient Characteristics and Outcomes

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 8092-8093

10.1182/blood-2022-164617

Evidence Supporting Light Chain Cast Nephropathy As a Myeloma Defining Event

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10068-10070

10.1182/blood-2022-162754

Patients with Monoclonal Gammopathy Have a High Rate of Second Symptomatic COVID-19 Infection Even after a Prior COVID-19 Infection and Vaccination

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10017-10019

10.1182/blood-2022-167181